Keywords: PC; prostate cancer; mPC; metastatic prostate cancer; ADT; androgen deprivation therapy; CRPC; castration resistant prostate cancer; mCRPC; metastatic CRPC; SNP; single nucleotide polymorphism; CNV; copy number variation; AR; androgen receptor; CTC; circu
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Prognostic value of circulating cell-free DNA in patients with pancreatic cancer: A systemic review and meta-analysis
Keywords: CfDNA; circulating cell-free DNA; CA19-9; carbohydrate antigen 19-9; CA242; carbohydrate antigen 242; ctDNA; circulating tumor DNA; ddPCR; droplet digital polymerase chain reaction; BEAMing; beads, emulsions, amplification, and magnetics; OS; overall
Circulating tumor DNA - Current state of play and future perspectives
Keywords: BEAMing; beads, emultion, amplification, magnetics; bp; base pairs; cfDNA; circulating cell-free DNA; CNS; central nervous system; CRC; colorectal cancer; CSF; cerebrospinal fluid; CTC; circulating tumor Cell; ctDNA; circulating tumor DNA; ddPCR; droplet
Plasma epidermal growth factor receptor mutation testing with a chip-based digital PCR system in patients with advanced non-small cell lung cancer
Keywords: ARMS; amplification refractory mutation system; BEAMing; beads, emulsions, amplification and magnetics; cfDNA; circulating free DNA; CI; confidence interval; ddPCR; droplet digital polymerase chain reaction; dPCR; digital polymerase chain reaction; EGFR;
Treatments for EGFR-mutant non-small cell lung cancer (NSCLC): The road to a success, paved with failures
Keywords: AE; adverse event; BEAMing; beads, emulsification, amplification, and magnetics; BIM; bcl2 interacting mediator of cell death or bcl2-like protein 11; CI; confidence interval; CNS; central nervous system; CR; complete remission; CSF; cerebrospinal fluid;
Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patients
Keywords: cfDNA; Cancer; Mutations; Capillary electrophoresis; BEAMing; COLD-PCR; Digital PCR;